Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹563 Cr₹475 Cr₹29 Cr₹-251 Cr₹-119 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹563 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹563 Cr
Mar2025₹475 Cr
Mar2024₹29 Cr
Mar2023₹-251 Cr
Mar2022₹-119 Cr

How is Net Cash Inflow / Outflow of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹563 Cr
18.65
Mar2025 ₹475 Cr
1,523.94
Mar2024 ₹29 Cr
Positive
Mar2023 ₹-251 Cr
Negative
Mar2022 ₹-119 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹42,071.3 Cr 1.5% -10.9% -8.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

1.5%

-10.9%

-8.5%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses